Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) - Related Studies

Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

This study has been completed.

Study NCT00080262. Last updated on June 27, 2008. Information provided by Bristol-Myers Squibb

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Metastases

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Neoplasm Metastasis

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Neoplastic Processes
		Pathologic Processes
		Skin Diseases

4	Interventions listed in this trial
		Ixabepilone

5	Additional drug interventions recognized in this trial
		Epothilones

6	More general drug interventions related to this trial
		Antimitotic Agents
		Antineoplastic Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		Bristol-Myers Squibb